Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
ITIH5, a novel member of the inter-α-trypsin inhibitor heavy chain family is downregulated in breast cancer
Ist Teil von
Cancer letters, 2004-02, Vol.204 (1), p.69-77
Ort / Verlag
Ireland: Elsevier Ireland Ltd
Erscheinungsjahr
2004
Link zum Volltext
Quelle
Access via ScienceDirect (Elsevier)
Beschreibungen/Notizen
The inter-α-trypsin inhibitor (ITI) family constitutes a group of proteins built up from one light chain and a variable set of heavy chains. Originally identified as plasma protease inhibitors, recent data indicate that ITI plays a role in extracellular matrix (ECM) stabilization and in prevention of tumor metastasis. Here we describe cloning as well as phylogenetic and expression analysis of a novel member of the heavy chain gene family,
ITIH5. ITIH5 contains the two domains conserved in all known ITIHs, the vault protein inter-alpha-trypsin (VIT) domain and a von Willebrand type A (vWA) domain. However, ITIH5 diverged early from a common ancestor of the other subfamilies. We found strong downregulation of
ITIH5 expression in breast tumors by real-time PCR and RNA in situ hybridization. While normal breast epithelial cells clearly express
ITIH5, expression is consistantly lost or strongly downregulated in invasive ductal carcinoma.
ITIH5 mRNA was neither detectable in cancerous nor benign breast cell lines. We propose that loss of
ITIH5 expression may be involved in breast cancer development.